Cardiovascular Health

Physicans’ Health Study: Healthy Lifestyle Obviates Risk of Heart Failure

By Staff Writer - Vol. 11, No. 2. , 2010

Statistically, the prevalence of heart failure increases with age, but a new prospective study is validating what holistic physicians have known for years: that a healthy lifestyle can markedly reduce the risk.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Vitamin E Tocotrienols Prevent Post-Stroke Neuronal Death

By Howard Simon | Contributing Writer - Vol. 11, No. 1. , 2010

A new study

shows that tocotrienols, an important component of naturally occurring Vitamin E, can prevent neural damage following ischemic stroke, potentially improving post-stroke outcomes.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Beyond NTDs, Folic Acid May Also Prevent Congenital Heart Problems

By Tori Hudson, ND | Contributing Writer - Vol. 10, No. 4. , 2009

Folic acid supplementation before and during pregnancy is widely recommended for preventing neural tube defects. New data indicate that it can also reduce the risk of cleft lip and congenital heart defects. At the other end of the age spectrum, folic acid in combination with vitamins B6 and B12 can reduce a woman’s risk of age-related macular degeneration.

Ubiquinol, the “Other CoQ10” May Help When Standard Forms Don’t

By Dallas Clouatre, PhD | Contributing Writer - Vol. 10, No. 4. , 2009

Clinical research on CoQ10 continues to point toward new uses including blood pressure reduction, glycemic control and potentially reducing risk of neurodegenration. CoQ10 in its reduced form, known as ubiquinol, often improves outcomes in conditions like as severe heart failure, when the more common ubiquinone form, has proven ineffective.

Hibiscus Hems Hypertension

By Tori Hudson, ND | Contributing Writer - Vol. 10, No. 4. , 2009

Hibiscus, a popular tea herb in many parts of the world, can markedly lower systolic blood pressure in type II diabetic people with mild hypertension, according to a recent clinical trial. On the other hand, black tea tends to increase systolic pressure.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

Home Sleep Monitoring Opens Gateway for Better Apnea Control

By Lee A. Surkin MD, FACC, FCCP | Contributing Writer - Vol. 10, No. 1. , 2009

Sleep apnea is common, debilitating and sometimes deadly. In the past, diagnosis involved costly sleep labs. New home monitoring devices provide greater patient comfort, save money, and generate revenue for primary care. Dr. Lee Surkin shares his clinical experience.

JUPITER: Separating the Solid Clinical Matter From the Hot Gas

By August West | Contributing Writer - Vol. 9, No. 4. , 2008

Gaseous Surface of Jupiter: Many cardiologists are hailing the massive JUPITER trial as a breakthrough, claiming that statin therapy could reduce cardiovascular risk even in patients with normal LDL.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

IDA Medical Foundation Seeks to “Democratize” Prevention

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 4. , 2008

Cutting edge early risk detection tests and preventive medicine have become the privilege of the wealthy. Dr. James Ehrlich, a pioneer in cardiovascular risk assessment, hopes to change that with his new Identify Disease in Advance Foundation, which will bring state-of-the-art preventive medicine to people who can least afford it but would most benefit from it.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

GGT: An Accurate, Inexpensive Predictor of Cardiometabolic Risk

By Erik L. Goldman | Editor-in-Chief - Vol. 9, No. 4. , 2008

Gamma glutamyl transferase (GGT) is a hepatic enzyme that indicates levels of oxidative stress in the liver. A large body of research suggests that it can also predict onset of insulin resistance, type 2 diabetes, and cardiovascular disease. At under $10 per test, it could be a very valuable asset in clinical practice.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.

“NO” News is Good News: Nitric Oxide for CVD & Diabetes

By Tamara Sofi-Smith, PhD candidate | Contributing Writer - Vol. 9, No. 4. , 2008

“From diabetes to hypertension, cancer to drug addiction, stroke to intestinal motility, memory and learning disorders to septic shock, sunburn to anorexia, male impotence to tuberculosis, there is probably no pathological condition where nitric oxide does not play an important role.”

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.